Urine stones of different chemical composition occurrence depending on the level of uricuria
- Authors: Prosiannikov M.Y.1, Anokhin N.V1, Golovanov S.A.1, Konstantinova O.V1, Sivkov A.V.1, Apolihin O.I.1
-
Affiliations:
- Scientific Research Institute of Urology and Interventional Radiology named after N.A. Lopatkin - Branch of the National Medical Research Radiological Centre of the Ministry of Health of Russian Federation
- Issue: Vol 10, No 2 (2020)
- Pages: 107-113
- Section: Original articles
- URL: https://journal-vniispk.ru/uroved/article/view/19223
- DOI: https://doi.org/10.17816/uroved102107-113
- ID: 19223
Cite item
Abstract
Introduction. According to modern concepts one of the key links in the pathogenesis of urolithiasis is metabolic lithogenic disturbances. The study of the complex effect of many factors on the metabolism of urolithiasis patient is the basis of modern scientific research. We studied the frequency of various chemical urinary stones occurrence depending on various levels of uricuria.
Materials and methods. Data from of 708 urolithiasis patients (303 men and 405 women) were analized. The results of blood and urine biochemical analysis and chemical composition of urinary stone were studied. The degree of uricuria was ranked by 10 intervals: from 0.4 to 14.8 mmol/day to assess the occurrence of different stones at various levels of uricuria.
Results. The incidence of calculi consisting of uric acid also increases with increasing levels of uric acid in the urine. An increase in the level of uricuria above 3.11 mmol/day is observed to increase calcium-oxalate stones occurrence. Decrease in the prevalence of carbonatapatite and struvite stones observed at an increase of urine uric acid excretion. At high levels of uric acid excretion, we found uric acid and calcium oxalate stones most often.
Conclusion. Control over the level of urinary acid excretion in urine is important in case of calcium-oxalate and uric acid urolithiasis.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Michail Y. Prosiannikov
Scientific Research Institute of Urology and Interventional Radiology named after N.A. Lopatkin - Branch of the National Medical Research Radiological Centre of the Ministry of Health of Russian Federation
Email: prosyannikov@gmail.com
MD, PhD, Head, Department of Urolithiasis
Russian Federation, MoscowNikolay V Anokhin
Scientific Research Institute of Urology and Interventional Radiology named after N.A. Lopatkin - Branch of the National Medical Research Radiological Centre of the Ministry of Health of Russian Federation
Author for correspondence.
Email: anokhinnikolay@yandex.ru
ORCID iD: 0000-0002-4341-4276
Researcher
Russian Federation, Moscow, RussiaSergey A. Golovanov
Scientific Research Institute of Urology and Interventional Radiology named after N.A. Lopatkin - Branch of the National Medical Research Radiological Centre of the Ministry of Health of Russian Federation
Email: sergeygol124@mail.ru
MD, PhD, Dr Med Sci, Professor, Head, Scientific Laboratory Department
Russian Federation, MoscowOlga V Konstantinova
Scientific Research Institute of Urology and Interventional Radiology named after N.A. Lopatkin - Branch of the National Medical Research Radiological Centre of the Ministry of Health of Russian Federation
Email: konstant-ov@yandex.ru
doctor of medical science, Chief researcher
Russian Federation, Moscow, RussiaAndrey V. Sivkov
Scientific Research Institute of Urology and Interventional Radiology named after N.A. Lopatkin - Branch of the National Medical Research Radiological Centre of the Ministry of Health of Russian Federation
Email: uroinfo@yandex.ru
candidate of medical science, deputy director
Russian Federation, Moscow, RussiaOleg I. Apolihin
Scientific Research Institute of Urology and Interventional Radiology named after N.A. Lopatkin - Branch of the National Medical Research Radiological Centre of the Ministry of Health of Russian Federation
Email: apolikhin.oleg@gmail.com
Corresponding Member of Russian Academy of Sciences, doctor of medical science, professor
Russian Federation, MoscowReferences
- Константинова О.В. Прогнозирование и принципы профилактики мочекаменной болезни: Автореф. дис. … докт. мед. наук. – М., 1999. – 39 с. [Konstantinova OV. Prognozirovaniye i printsipy profilaktiki mochekamennoy bolezni. [dissertation abstract] Moscow; 1999. 39 р. (In Russ.)]. Доступно по: https://search.rsl.ru/ru/record/01000223000. Ссылка активна на 10.02.2020.
- Голованов С.А. Клинико-биохимические и физико-химические критерии течения и прогноза мочекаменной болезни: Дис. … докт. мед. наук. – М., 2003. – 314 с. [Golovanov SA. Kliniko-biokhimicheskiye i fiziko-khimicheskiye kriterii techeniya i prognoza mochekamennoy bolezni. [dissertation] Moscow; 2003. 314 р. (In Russ.)]. Доступно по: https://search.rsl.ru/ru/record/01004311319. Ссылка активна на 10.02.2020.
- Reichard C, Gill BC, Sarkissian C, et al. 100 % uric acid stone formers: what makes them different? Urology. 2015;85(2): 296-298. https://doi.org/10.1016/j.urology.2014.10.029.
- Trinchieri A, Montanari E. Biochemical and dietary factors of uric acid stone formation. Urolithiasis. 2018;46(2):167-172. https://doi.org/10.1007/s00240-017-0965-2.
- Torricelli FC, De S, Liu X, et al. Can 24-hour urine stone risk profiles predict urinary stone composition? J Endourol. 2014;28(6):735-738. https://doi.org/10.1089/end.2013. 0769.
- Cicerello E. Uric acid nephrolithiasis: an update. Urologia. 2018;85(3):93-98. https://doi.org/10.1177/0391560318766823.
- Moe OW, Xu LH. Hyperuricosuric calcium urolithiasis. J Nephrol. 2018;31(2):189-196. https://doi.org/10.1007/s40620-018-0469-3.
- Hirasaki S, Koide N, Fujita K, et al. Two cases of renal hypouricemia with nephrolithiasis. Intern Med. 1997;36(3):201-205. https://doi.org/10.2169/internalmedicine.36.201.
- Kenny JE, Goldfarb DS. Update on the pathophysiology and management of uric acid renal stones. Curr Rheumatol Rep. 2010;12(2):125-129. https://doi.org/10.1007/s11926-010-0089-y.
- Moe OW, Abate N, Sakhaee K. Pathophysiology of uric acid nephrolithiasis. Endocrinol Metab Clin North Am. 2002;31(4):895-914. https://doi.org/10.1016/s0889-8529(02)00032-4.
- Lonsdale K. Epitaxy as a growth factor in urinary calculi and gallstones. Nature. 1968;217(5123):56-58. https://doi.org/10.1038/217056a0.
- Coe FL, Lawton RL, Goldstein RB, Tembe V. Sodium urate accelerates precipitation of calcium oxalate in vitro. Proc Soc Exp Biol Med. 1975;149(4):926-9. https://doi.org/10.3181/00379727-149-38928.
- Pak CY, Arnold LH. Heterogeneous nucleation of calcium oxalate by seeds of monosodium urate. Proc Soc Exp Biol Med. 1975;149(4): 930-932. https://doi.org/10.3181/00379727-149-38929.
- Pak CY, Barilla DE, Holt K, et al. Effect of oral purine load and allopurinol on the crystallization of calcium salts in urine of patients with hyperuricosuric calcium urolithiasis. Am J Med. 1978;65(4): 593-599. https://doi.org/10.1016/0002-9343(78)90846-x.
- Robertson WG. Physical chemical aspects of calcium stone-formation in the urinary tract. In: Fleisch H, Robertson WG, Smith LH, Vahlensieck W. Urolithiasis Research. New York: Plenum Press; 1976. Р. 25-39. https://doi.org/10.1007/978-1-4613-4295-3_2.
- Donaldson JF, Ruhayel Y, Skolarikos A, et al. Treatment of bladder stones in adults and children: a systematic review and meta-analysis on behalf of the european association of urology urolithiasis guideline panel. Eur Urol. 2019;76(3):352-367. https://doi.org/10.1016/j.eururo.2019.06.018.
- Englert KM, McAteer JA, Lingeman JE, Williams JC, Jr. High carbonate level of apatite in kidney stones underlines infection, but is it predictive? Urolithiasis. 2013;41(5):389-394. https://doi.org/10.1007/s00240-013-0591-6.
- Frassetto L, Kohlstadt I. Treatment and prevention of kidney stones: an update. Am Fam Physician. 2011;84(11):1234-1242.
- Hall PM. Nephrolithiasis: treatment, causes, and prevention. Cleve Clin J Med. 2009;76(10):583-591. https://doi.org/10.3949/ccjm.76a.09043.
- Cicerello E, Mangano M, Cova GD, et al. Metabolic evaluation in patients with infected nephrolithiasis: is it necessary? Arch Ital Urol Androl. 2016;88(3):208-211. https://doi.org/10.4081/aiua.2016.3.208.
- Iqbal MW, Shin RH, Youssef RF, et al. Should metabolic evaluation be performed in patients with struvite stones? Urolithiasis. 2017;45(2):185-192. https://doi.org/10.1007/s00240-016-0893-6.
Supplementary files
